LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 497
Next
>>
>
1 to 25 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
MCF7	XMD11-85h	0.04	uM	LJP6	1	P24	72	hr	1209	3667	4093	0.8959	0.8523
MCF7	Trametinib	0.04	uM	LJP5	2	P24	72	hr	1209	2145	4093	0.5241	0.3244
MCF 10A	Trametinib	0.04	uM	LJP5	1	P24	72	hr	962	1801	10605	0.1698	0.0870
MCF 10A	Trametinib	0.04	uM	LJP5	3	P24	72	hr	962	1576	10605	0.1486	0.0637
MCF7	XMD11-85h	0.04	uM	LJP6	3	P24	72	hr	1209	3379	4093	0.8256	0.7524
MCF7	Trametinib	0.04	uM	LJP5	1	P24	72	hr	1209	2044	4093	0.4994	0.2894
Hs 578T	XMD11-85h	0.04	uM	LJP6	2	P24	72	hr	658	3557	3846	0.9248	0.9093
MCF 10A	XMD11-85h	0.04	uM	LJP6	3	P24	72	hr	962	11312	10605	1.0667	1.0733
Hs 578T	Trametinib	0.04	uM	LJP5	3	P24	72	hr	658	1140	3846	0.2964	0.1511
MCF 10A	Trametinib	0.04	uM	LJP5	2	P24	72	hr	962	1994	10605	0.1880	0.1070
MCF7	XMD11-85h	0.04	uM	LJP6	2	P24	72	hr	1209	3276	4093	0.8004	0.7167
BT-20	XMD11-85h	0.04	uM	LJP6	2	P24	72	hr	1097	2594	3769	0.6882	0.5601
Hs 578T	Trametinib	0.04	uM	LJP5	2	P24	72	hr	658	1050	3846	0.2730	0.1229
BT-20	Trametinib	0.04	uM	LJP5	3	P24	72	hr	1097	3250	3769	0.8622	0.8056
BT-20	XMD11-85h	0.04	uM	LJP6	3	P24	72	hr	1097	2869	3769	0.7611	0.6630
BT-20	Trametinib	0.04	uM	LJP5	2	P24	72	hr	1097	3198	3769	0.8484	0.7861
MCF 10A	XMD11-85h	0.04	uM	LJP6	1	P24	72	hr	962	10703	10605	1.0092	1.0102
MCF 10A	XMD11-85h	0.04	uM	LJP6	2	P24	72	hr	962	10821	10605	1.0204	1.0224
BT-20	Trametinib	0.04	uM	LJP5	1	P24	72	hr	1097	2687	3769	0.7128	0.5949
Hs 578T	XMD11-85h	0.04	uM	LJP6	1	P24	72	hr	658	3405	3846	0.8853	0.8616
Hs 578T	Trametinib	0.04	uM	LJP5	1	P24	72	hr	658	1127	3846	0.2930	0.1471
Hs 578T	XMD11-85h	0.04	uM	LJP6	3	P24	72	hr	658	3556	3846	0.9246	0.9090
BT-20	XMD11-85h	0.04	uM	LJP6	1	P24	72	hr	1097	2887	3769	0.7659	0.6697
MDA-MB-231	XMD11-85h	0.04	uM	LJP6	1	P24	72	hr	1235	3343	4513	0.7406	0.6429
MCF7	Trametinib	0.04	uM	LJP5	3	P24	72	hr	1209	2376	4093	0.5805	0.4045

<
<<
Previous
Page 1 of 497
Next
>>
>
1 to 25 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)